HealthTree Logo
search more_vert
person Sign In / Create Account
Targeting FLT3 Positive AML with New & Improved Therapies with Dr. Margaret Kasner
Targeting FLT3 Positive AML with New & Improved Therapies with Dr. Margaret Kasner image
HealthTree Podcast for AML
event Feb 07, 2022 / 01:00PM EST

Event Description

About 30% of acute myeloid leukemia patients have developed a mutation in the FLT3 gene. Up until recently, this specific mutation usually resulted in poor treatment outcomes. Today, we have several drugs designed to directly target this mutation and even more progress is occurring with newer drugs and various treatment combinations in clinical trials.

Dr. Kasner, an AML expert from the Sidney Kimmel Cancer Center at Thomas Jefferson University, will summarize key developments and clinical trials currently underway for FLT3 positive AML. If you have a FLT3 mutation, this radio show episode is definitely for you. 


Schedule & Agenda

Katie Braswell
Welcome, announcements and introduction
Dr. Kasner
Dr. Kasner will explain the major clinical trials currently underway for testing existing and novel drugs designed to target the FLT3 mutation found in acute myeloid leukemia.
Question and Answer Session
Audience is able to call in to the radio show (515) 602-9728 to ask Dr. Kasner questions about what was discussed during our interview today.

Speakers & Moderators

The panelist Katie Braswell
Katie Braswell
Dallas, Texas

Katie joined the HealthTree Foundation as the Community Director for AML in 2021. She is a registered dietitian who previously worked at the VA hospital in Dallas, Texas where she coached veterans with blood cancer on how to use nutrition to improve their treatment outcomes and minimize cancer-related side effects. Katie is passionate about health education and patient empowerment. In her spare time, she loves to experiment with new recipes in the kitchen, spend time running outdoors, and travel to new places.

Read Bio
The panelist Margaret Kasner, MD
Margaret Kasner, MD
Philadelphia, Pennsylvania

Associate Professor of Medical Oncology in the Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation Division, Section Leader of the Leukemia Program in the Department of Medical Oncology and Co-Medical Director at the Clinical Trials Office, Sidney Kimmel Cancer Center at Thomas Jefferson University

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.


Get In Touch With Us




Get the latest thought leadership on Acute Myeloid Leukemia delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Acute Myeloid Leukemia Newsletter" for Acute Myeloid Leukemia news, life with Acute Myeloid Leukemia stories, Acute Myeloid Leukemia clinical trials, Acute Myeloid Leukemia 101 articles and events with Acute Myeloid Leukemia experts.

Thanks to our HealthTree Community for Acute Myeloid Leukemia Sponsors:

Astellas Pharma

Follow Us

facebook instagram youtube